MYELOABLATIVE DOSES OF BUSULFAN AND FLUDARABINE AS CONDITIONING FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN NON-HODGKIN'S LYMPHOMA

被引：1
|
作者：
Figueroa, J. [1 ]
Perkins, J. [1 ]
Anassetti, C. [1 ]
Tomblyn, M. [1 ]
Field, T. [1 ]
Fernandez, H. [1 ]
Ochoa, J. [1 ]
Perez, L. [1 ]
Alsina, M. [1 ]
Locke, F. [1 ]
Nishihori, T. [1 ]
Pidala, J. [1 ]
Ayala, E. [1 ]
机构：
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2012年 / 18卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2011.12.240
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
252
引用
收藏
页码：S297 / S297
页数：1
相关论文
共 50 条
  • [41] Autologous and allogeneic stem cell transplantation of peripheral T/NK cell non-Hodgkin's lymphoma
    Bishop, M. R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 : 9 - 9
  • [42] Treosulfan/fludarabine - a low toxicity but myeloablative conditioning for allogeneic hematopoietic stem cell transplantation
    Holowiecki, J
    Giebel, S
    Wojnar, J
    Krawczyk-Kulis, M
    Wylezol, I
    Kruzel, T
    Markiewicz, M
    BLOOD, 2004, 104 (11) : 292A - 292A
  • [43] The role of allogeneic transplantation in non-Hodgkin's lymphoma
    Peggs, KS
    Mackinnon, S
    Linch, DC
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (02) : 153 - 168
  • [44] Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells
    Bornhäuser, M
    Storer, B
    Slattery, JT
    Appelbaum, FR
    Deeg, HJ
    Hansen, J
    Martin, PJ
    McDonald, GB
    Nichols, WG
    Radich, J
    Woolfrey, A
    Jenke, A
    Schleyer, E
    Thiede, C
    Ehninger, G
    Anasetti, C
    BLOOD, 2003, 102 (03) : 820 - 826
  • [45] Non-myeloablative regimen consisting of busulfan, fludarabine, and ATG for allogeneic peripheral blood stem cell transplantation.
    Mayer, J
    Koristek, Z
    Krahulová, M
    Vorlicek, J
    EXPERIMENTAL HEMATOLOGY, 1999, 27 (07) : 131 - 131
  • [46] Autologous stem-cell transplantation in Hodgkin's and non-Hodgkin's lymphoma
    Greinix, HT
    ACTA MEDICA AUSTRIACA, 2000, 27 : 25 - 29
  • [47] Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL)
    Jae-Cheol Jo
    Jin Seok Kim
    Je-Hwan Lee
    Jung-Hee Lee
    Sung-Nam Lim
    Sang Min Lee
    Sung-Soo Yoon
    In-Ho Kim
    Sung Hwa Bae
    Yoo Jin Lee
    Yunsuk Choi
    Won-Sik Lee
    Bone Marrow Transplantation, 2020, 55 : 1466 - 1468
  • [48] Clinical and molecular disease eradication in patients with poor prognosis non-Hodgkin lymphoma by allogeneic haematopoietic stem cell transplantation with reduced-intensity or myeloablative conditioning
    Mitterbauer, M
    Kalhs, P
    Jaeger, U
    Mannhalter, C
    Rabitsch, W
    Fischer, G
    Dieckmann, K
    Simonitsch-Klupp, I
    Hoecker, P
    Hinterberger, W
    Rosenmayr, A
    Mitterbauer, G
    Greinix, HT
    BONE MARROW TRANSPLANTATION, 2005, 35 : S73 - S73
  • [49] Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL)
    Jo, Jae-Cheol
    Kim, Jin Seok
    Lee, Je-Hwan
    Lee, Jung-Hee
    Lim, Sung-Nam
    Lee, Sang Min
    Yoon, Sung-Soo
    Kim, In-Ho
    Bae, Sung Hwa
    Lee, Yoo Jin
    Choi, Yunsuk
    Lee, Won-Sik
    BONE MARROW TRANSPLANTATION, 2020, 55 (07) : 1466 - 1468
  • [50] Busulfan, etoposide, cytarabine and melphalan (BUEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-hodgkin lymphoma (NHL)
    Jo, Jae-Cheol
    Kim, Jin-Seok
    Lee, Je-Hwan
    Lee, Jung-Hee
    Im, Seong Nam
    Lee, Won-Sik
    Lee, Sang-Min
    Yoon, Sung-Soo
    Kim, In-Ho
    Choi, Yun Suk
    Bae, Seong Hwa
    BONE MARROW TRANSPLANTATION, 2019, 54 : 209 - 210
12345